<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Biotechnology SEC 151 Unit 4 | 2nd Semester Notes - Knowlet</title>
    <meta name="description" content="Comprehensive notes for Biotechnology (BTC SEC 151) Unit 4: Immune System Disorders, as per NEP syllabus. Covers autoimmune diseases (Hashimoto's, Myasthenia Gravis, SLE, RA) and immunodeficiency (HIV/AIDS).">
    <meta name="keywords" content="Biotechnology SEC 151, Unit 4, Immunology, Autoimmune Disease, Hashimoto's, Myasthenia Gravis, Lupus (SLE), Rheumatoid Arthritis, Immunodeficiency, HIV, AIDS, Assam University, NEP Syllabus">
    
    <link rel="stylesheet" href="../../../../assets/styles/units.css">
   <link rel="stylesheet" href="../../../../assets/styles/supabase.css">
    <style>
        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, sans-serif;
            line-height: 1.6;
            background-color: #f4f7f6;
            color: #333;
            margin: 0;
            padding: 20px;
        }
        .container {
            max-width: 1000px;
            margin: 0 auto;
            background-color: #ffffff;
            border: 1px solid #dcdcdc;
            border-radius: 8px;
            padding: 25px;
            box-shadow: 0 4px 12px rgba(0,0,0,0.05);
        }
        h1, h2, h3 {
            color: #2c3e50;
            border-bottom: 2px solid #00796b; /* Teal theme */
            padding-bottom: 5px;
        }
        h1 {
            font-size: 2.2em;
            text-align: center;
            color: #004d40;
        }
        h2 {
            font-size: 1.8em;
            color: #00796b;
        }
        h3 {
            font-size: 1.4em;
            color: #00897b;
            border-bottom: 1px dashed #ccc;
        }
        p {
            font-size: 1.1em;
            margin-bottom: 15px;
        }
        ul, ol {
            margin-bottom: 15px;
            padding-left: 25px;
        }
        li {
            margin-bottom: 8px;
        }
        table {
            width: 100%;
            border-collapse: collapse;
            margin: 20px 0;
            font-size: 1em;
        }
        table, th, td {
            border: 1px solid #bdc3c7;
        }
        th, td {
            padding: 12px;
            text-align: left;
        }
        th {
            background-color: #00796b;
            color: #ffffff;
        }
        tr:nth-child(even) {
            background-color: #ecf0f1;
        }
        tr:hover {
            background-color: #e0f2f1;
        }
        blockquote {
            background-color: #e0f2f1;
            border-left: 5px solid #00796b;
            margin: 15px 0;
            padding: 10px 20px;
            font-style: italic;
        }
        .exam-tip {
            background-color: #fef9e7;
            border: 1px solid #f1c40f;
            border-radius: 5px;
            padding: 15px;
            margin: 15px 0;
        }
        .exam-tip strong {
            color: #d35400;
        }
        .toc {
            background: #e0f7fa;
            border: 1px solid #b2ebf2;
            border-radius: 5px;
            padding: 15px;
            margin-bottom: 25px;
        }
        .toc h2 {
            border-bottom: none;
            color: #004d40;
            margin-top: 0;
        }
        .toc ul {
            list-style-type: none;
            padding-left: 0;
        }
        .toc li a {
            text-decoration: none;
            color: #00796b;
        }
        .toc li a:hover {
            text-decoration: underline;
        }
    </style>
</head>
<body>
    <div class="container">
        <h1>Unit 4: Immune System Disorders</h1>

        <div class="toc">
            <h2>Table of Contents</h2>
            <ul>
                <li><a href="#autoimmunity">1. Autoimmune Diseases</a></li>
                <li><a href="#organ-specific">2. Organ-Specific Autoimmune Diseases</a></li>
                <li><a href="#systemic">3. Systemic Autoimmune Diseases</a></li>
                <li><a href="#immunodeficiency">4. Immunodeficiency</a></li>
                <li><a href="#hiv-aids">5. HIV and AIDS</a></li>
            </ul>
        </div>

        <h2 id="autoimmunity">1. Autoimmune Diseases </h2>
        <p><strong>Autoimmunity</strong> is a condition in which the body's immune system fails to maintain <strong>self-tolerance</strong> (the ability to recognize its own components as "self"). This failure leads to an immune response against its own cells and tissues, as if they were foreign invaders.</p>
        <p>The immune system creates <strong>autoantibodies</strong> (antibodies against self-antigens) or <strong>autoreactive T-cells</strong>, which attack and destroy healthy tissue.</p>
        <p>These diseases are classified into two main groups: organ-specific and systemic.</p>

        <h2 id="organ-specific">2. Organ-Specific Autoimmune Diseases </h2>
        <p>In this type, the immune response is directed against a specific antigen found in only one organ or tissue.</p>

        <h3>a) Hashimoto's Disease (Hashimoto's thyroiditis) </h3>
        <ul>
            <li><strong>Target Organ:</strong> Thyroid gland.</li>
            <li><strong>Mechanism:</strong> Autoantibodies and autoreactive T-cells attack thyroid gland proteins (like thyroglobulin and thyroid peroxidase).</li>
            <li><strong>Result:</strong> This leads to the gradual destruction of the thyroid gland, preventing it from producing thyroid hormone. This causes <strong>hypothyroidism</strong> (underactive thyroid), with symptoms like fatigue, weight gain, and cold intolerance.</li>
        </ul>

        <h3>b) Myasthenia Gravis </h3>
        <ul>
            <li><strong>Target Tissue:</strong> Neuromuscular junction (the connection between nerves and muscles).</li>
            <li><strong>Mechanism:</strong> <span id="spap_8">Autoantibodies bind to and <strong>block or destroy the acetylcholine (ACh) receptors</strong> on muscle cells.</span> ACh is the neurotransmitter that signals muscles to contract.</li>
            <li><strong>Result:</strong> With receptors blocked, the muscle cannot receive the nerve signal properly. This causes profound <strong>muscle weakness</strong> and fatigue, often affecting the eyes (drooping eyelids), face, and throat first.</li>
        </ul>
        

        <h2 id="systemic">3. Systemic Autoimmune Diseases </h2>
        <p>In this type, the immune response is directed against multiple, widespread self-antigens found in different organs and tissues throughout the body.</p>

        <h3>a) Systemic Lupus Erythematosus (SLE) </h3>
        <ul>
            <li><strong>Target:</strong> Widespread (systemic).</li>
            <li><strong>Mechanism:</strong> Characterized by a wide array of autoantibodies, especially <strong>anti-nuclear antibodies (ANAs)</strong>, which target components of the cell nucleus (like DNA and histones).</li>
            <li><strong>Result:</strong> These antibodies form <strong>immune complexes</strong> (clumps of antigen-antibody) that get trapped in small blood vessels in the skin, kidneys, joints, and brain. This triggers widespread <strong>inflammation</strong>, leading to symptoms like a "butterfly" rash on the face, joint pain, kidney damage, and fatigue.</li>
        </ul>

        <h3>b) Rheumatoid Arthritis (RA) </h3>
        <ul>
            <li><strong>Target:</strong> Primarily the <strong>synovium</strong> (the lining of the joints).</li>
            <li><strong>Mechanism:</strong> Autoreactive T-cells and autoantibodies (like <strong>rheumatoid factor</strong>) attack the joint lining, causing chronic inflammation.</li>
            <li><strong>Result:</strong> The inflammation gradually destroys the cartilage and bone within the joint, leading to pain, swelling, stiffness, and eventual joint deformity.</li>
        </ul>

        <h2 id="immunodeficiency">4. Immunodeficiency </h2>
        <blockquote>
            <p><strong>Immunodeficiency</strong> is a state in which the immune system's ability to fight infectious diseases and cancer is compromised or entirely absent. This makes the person highly susceptible to <strong>opportunistic infections</strong> (infections caused by pathogens that don't normally cause disease in a healthy person).</p>
        </blockquote>
        <ul>
            <li><strong>Primary (Congenital) Immunodeficiency:</strong> Caused by a genetic defect. The person is born with a missing or impaired part of the immune system.</li>
            <li><strong>Secondary (Acquired) Immunodeficiency:</strong> The immune system is damaged *after* birth by an external factor. This is more common.
                <ul>
                    <li><strong>Causes:</strong> Malnutrition, certain cancers (e.g., leukemia), immunosuppressive drugs (for transplants or autoimmunity), and <strong>infection (e.g., HIV)</strong>.</li>
                </ul>
            </li>
        </ul>

        <h2 id="hiv-aids">5. HIV and AIDS </h2>
        <p>This is the most well-known example of a secondary immunodeficiency.</p>
        
        <h3>a) HIV (Human Immunodeficiency Virus)</h3>
        <ul>
            <li><strong>What it is:</strong> A <strong>retrovirus</strong> (it uses reverse transcriptase to insert its RNA genome into the host's DNA).</li>
            <li><strong>Primary Target:</strong> <span id="spap_9">HIV specifically infects and destroys <strong>CD4+ T-helper cells</strong>.</span></li>
        </ul>
        
        
        <div class="exam-tip">
            <strong>Why is targeting CD4+ T-helper cells so devastating?</strong>
            <p>As covered in Unit 1 and 3, T-helper cells are the "generals" of the immune system. They are required to activate *both* B-cells (humoral immunity) and Cytotoxic T-cells (cellular immunity). By destroying the T-helper cells, HIV cripples the entire adaptive immune response.</p>
        </div>

        <h3>b) AIDS (Acquired Immunodeficiency Syndrome)</h3>
        <ul>
            <li><strong>What it is:</strong> AIDS is not the virus itself; it is the *syndrome* (a set of symptoms) that develops in the late stages of HIV infection.</li>
            <li><strong>Diagnosis:</strong> A person with HIV is diagnosed with AIDS when their <strong>CD4+ T-cell count drops below 200 cells/ÂµL</strong> (a healthy count is 500-1,500) OR when they develop one or more specific <strong>opportunistic infections</strong> (e.g., <em>Pneumocystis</em> pneumonia, Kaposi's sarcoma).</li>
            <li><strong>Result:</strong> Without a functional immune system, the patient cannot fight off common germs and is at high risk of death from opportunistic infections or certain cancers.</li>
        </ul>
        
    </div>
    <script src="../../../../assets/scripts/units.js"></script>
    <div id="app"></div>

    <!-- Supabase client -->
    <script src="https://cdn.jsdelivr.net/npm/@supabase/supabase-js@2"></script>
    <script src="../../../../assets/scripts/supabase.js"></script>
</body>
</html>